Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 1,153,087.0 | $297.9M | 12.06% | +212K | +22.5% | $258.32 | +15.9% |
| 2 | CELC | CELCUITY INC | Healthcare | 1,284,378.0 | $146.6M | 5.94% | -524K | -29.0% | $114.14 | +21.1% |
| 3 | TGTX | TG THERAPEUTICS INC | Healthcare | 4,029,319.0 | $133.9M | 5.42% | +890K | +28.4% | $33.22 | +17.0% |
| 4 | PODD | INSULET CORP | Healthcare | 562,500.0 | $118.0M | 4.78% | +412K | +275.0% | $209.84 | -26.2% |
| 5 | NVCR | NOVOCURE LTD | Healthcare | 10,492,391.0 | $114.4M | 4.63% | +2.0M | +23.0% | $10.90 | +64.8% |
| 6 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 187,187.0 | $111.0M | 4.50% | +127K | +212.0% | $592.98 | -4.1% |
| 7 | — | PRAXIS PRECISION MEDICINES I | — | 330,517.0 | $106.5M | 4.31% | -32K | -8.9% | $322.19 | — |
| 8 | VCEL | VERICEL CORP | Healthcare | 2,549,079.0 | $82.0M | 3.32% | +1.8M | +233.7% | $32.17 | +8.0% |
| 9 | ALKS | ALKERMES PLC | Healthcare | 1,970,864.0 | $69.7M | 2.82% | +648K | +49.0% | $35.36 | +4.1% |
| 10 | ANIP | ANI PHARMACEUTICALS INC | Healthcare | 820,243.0 | $63.1M | 2.56% | +334K | +68.7% | $76.90 | +7.6% |
| 11 | — | GLOBUS MED INC | — | 729,467.0 | $62.9M | 2.54% | -158K | -17.8% | $86.16 | — |
| 12 | GERN | GERON CORP | Healthcare | 41,508,659.0 | $61.8M | 2.50% | +18.2M | +78.2% | $1.49 | -14.1% |
| 13 | TWST | TWIST BIOSCIENCE CORP | Healthcare | 1,226,629.0 | $58.3M | 2.36% | -635K | -34.1% | $47.52 | +27.5% |
| 14 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 1,449,915.0 | $45.7M | 1.85% | +540K | +59.3% | $31.50 | +3.8% |
| 15 | BBNX | BETA BIONICS INC | Healthcare | 4,354,501.0 | $43.6M | 1.77% | +1.8M | +71.8% | $10.02 | +18.0% |
| 16 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 131,650.0 | $43.6M | 1.76% | +62K | +88.1% | $330.87 | -10.1% |
| 17 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 1,726,908.0 | $40.3M | 1.63% | -520K | -23.1% | $23.36 | -14.6% |
| 18 | INDV | INDIVIOR PHARMACEUTICALS INC | Healthcare | 1,274,000.0 | $38.8M | 1.57% | NEW | — | $30.48 | +23.1% |
| 19 | NPCE | NEUROPACE INC | Healthcare | 2,932,207.0 | $38.6M | 1.56% | +229K | +8.5% | $13.15 | +28.7% |
| 20 | LIVN | LIVANOVA PLC | Healthcare | 582,500.0 | $37.0M | 1.50% | +15K | +2.6% | $63.56 | +16.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%